National Research Corporation Board of Directors Announces Use of Cash


Lincoln, Nebraska, Aug. 19, 2013 (GLOBE NEWSWIRE) -- National Research Corporation (NASDAQ: NRCIA|NRCIB) announced today that its Board of Directors has set forth the company's use of cash, including future cash dividends.

"Management and the Board of Directors have identified a number of organic and inorganic investment opportunities, which could materially increase the growth trajectory of the company. One such investment was made in Customer Connect, LLC in June 2013. In order to maximize available cash for these investments, the company is suspending cash dividend payments through the year 2014. Cash dividend payments to shareholders are currently anticipated to resume in 2015 and be in the range of 10-20% of free cash flow," commented Michael D. Hays, Chief Executive Officer.

The payment and amount of future dividends, if any, are subject to change and will continue to be at the discretion of the Board of Directors and depend upon the company's future earnings, financial condition, general business conditions, alternative uses of the company's earnings and other factors.

About National Research Corporation

For more than 30 years, National Research Corporation (NASDAQ: NRCIA|NRCIB) has been at the forefront of patient-centered care. Today, the company's focus on empowering customer-centric healthcare across the continuum extends patient-centered care to incorporate families, communities, employees, senior housing residents, and other stakeholders. National Research's healthcare analytics products and solutions identify a path to better quality outcomes and patient experiences for home health agencies.

Recognized by Modern Healthcare as one of the largest patient satisfaction firms in the U.S., National Research is dedicated to representing the true voice of patients and other healthcare stakeholders. This integration of cross-continuum metrics and analytics uncovers insights for effective performance improvement, quality measurement, care transitions, and many other factors that impact population health management.

National Research is headquartered in Lincoln, Nebraska. For more information, call 800-388-4264, write to, or visit

This press release includes "forward-looking" statements related to the Company that can generally be identified as describing the Company's future plans, objectives or goals. Such forward-looking statements are subject to risks and uncertainties that could cause actual results or outcomes to differ materially from those currently anticipated. These forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. For further information about the factors that could affect the Company's future results, please see the Company's filings with the Securities and Exchange Commission.


CONTACT: Kevin R. Karas Chief Financial Officer 402-475-2525

Source:National Research Corporation